Primary study on the construction and development of experimental pathology in medical supervisionJIN Yi, CHAO Lin-lin, JIN Zhi-hu, GAN Yu-xi, ZANG De-yue, CAO Sheng-tian, FENG Shan-shan, DENG Jun-cheng, LIN Bai-you, HUANG Hou-shuang, XUE You-an, WANG Ru-xian, XIE Yong-jiao, XIE Tian-zhu, CHEN Run-hua, SUN Xiao, LI Jing417-421
The main responsibility of marketing authorization holder in drug change management in the new situationZHANG Bao-mei, GAO Xuan, LU Xiao-jun422-426
Research progress of P2X7 receptor involved in neuroinflammatory mechanism and potential drug targetsLIU Dong-ni, YANG Ying-lin, WANG Yue-hua, DU Guan-hua435-441
Progress on dosage regimen adjustment of antibiotic in severe patients with hypoalbuminemiaHUANG Jian, WU A-long, XU Bing-fa442-447
Advances on animal models and drug development of myeloproliferation neoplasmsFENG Lu-yao, SHI Zhen-gang, JIANG De-jian, XIN Hong-ya448-454
The development of glabridin-loaded sustained microneedles and the evaluation of drug release in vitro and in vivoHU Yan-ping, LIAO Lang-kun, LIAO Shi-ji, HU Qiao-hong, HAN Bin, QIU Yu-qin455-463
Optimization of extraction process of Jingulian Capsules by orthogonal testZHANG Xiong-li, FU Zhi-li, LIU Hui, XIAO Jin-chao, PU Jian, YUAN Hong-fei, LI Yong-jun, ZHENG Lin, HUANG Yong464-469
Stability of two kinds of microecologics during applicationXU Wen-feng, XU Shuo, ZHANG Shan-shan, GUO Si-rui, JIN Peng-fei, HU Xin470-476